Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines

Please use this identifier to cite or link to this item: http://ir.sinica.edu.tw/handle/201000000A/83485

Title:	Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines
Authors:	Teng, W Chang, TT Yang, HI Peng, CY Su, CW Su, TH Hu, TH Yu, ML Yang, HC Wu, JC
Issue Date:	2021
Relation:	Hepatology international 15, 1421-1430
URI:	http://ir.sinica.edu.tw/handle/201000000A/83485
ISSN:	http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=1936-0533&DestApp=JCR&RQ=IF_CAT_BOXPLOT
URL:	http://dx.doi.org/10.1007/s12072-021-10263-x
Appears in Collections:	基因體研究中心

Show full item record

Check